Nevertheless, anti-GAD65-associated SPS is likely to be an exception because more than 70% of patients can obtain relief from IVIG, and notably, the abovementioned clinical trial further clarifies the validity of IVIG [44]. Here, GAD2 is linked to stiff-person syndrome.